Aktiesnakken — Februar 2011
-
Nu Origio - et fertilitetsplay
-
Medtech med biotech pipeline
-
Omsætning 300mdkk
-
Cashflow 10m. Marketcap 450 mdkk
-
Markedet burde være meget større. Potential 100. X større
-
God stærk præsemtation
-
Bric lande måske et godt vækstmarkedet
-
Massef af megatrends understøtte fertilitetsmarkedet
-
Fedme, uddannelse og befolkningsvækst giver større markedet
-
Ret spændende branche
-
Origio er det største fokuserede selskab i verden
-
Undtaget stor oharma
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind